<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.weightlossrankings.org/research/psyllium-husk-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T00:00:00.000Z</news:publication_date>
      <news:title>Psyllium Husk for Weight Loss: What the Evidence Says</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/green-tea-extract-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T00:00:00.000Z</news:publication_date>
      <news:title>Green Tea Extract for Weight Loss: Small Effect, Real Liver Risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/chromium-picolinate-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T00:00:00.000Z</news:publication_date>
      <news:title>Chromium Picolinate for Weight Loss: Does It Work?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/que-es-orforglipron-foundayo</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Qué es orforglipron (Foundayo): mecanismo, fabricante y pronunciación</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-cese-tabaquismo-nicotina-vareniclina-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para cese del tabaquismo: Chantix, bupropión y combinaciones con nicotina</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-esofago-barrett-vigilancia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en esófago de Barrett: pérdida de peso y vigilancia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-rinosinusitis-cronica-polipos-nasales-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en rinosinusitis crónica y pólipos nasales: evidencia y biológicos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/receptor-gip-abreviatura-medica-explicada</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Qué es GIP: receptor GIP explicado (y por qué Mounjaro/Zepbound lo activan junto al GLP-1)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/aguacate-perdida-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Es bueno el aguacate para perder peso? Revisión honesta de la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/surmount-osa-tirzepatida-apnea-sueno</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatida para la apnea del sueño: qué mostró SURMOUNT-OSA y la aprobación de la FDA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-suspension-recuperacion-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Suspender Wegovy, Zepbound u Ozempic: evidencia de rebote y planificación de transición</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-ashwagandha-cortisol-comer-emocional-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Ashwagandha y GLP-1: cortisol, comer emocional y evidencia de uso combinado</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-benzodiazepinas-ansiedad-combinacion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + benzodiazepinas para ansiedad: evidencia de combinación segura</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/guia-inyecciones-perdida-peso</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Guía de inyecciones para perder peso 2026: opciones, eficacia, costo y seguridad</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sobreviviente-cancer-guia-paciente-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para sobrevivientes de cáncer: plan de acción y evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/guia-principiantes-inyeccion-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Inyección de GLP-1: qué es, qué marcas, cómo funciona (guía para principiantes)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-acromegalia-cushing-hipofisis-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en acromegalia y Cushing: consideraciones de enfermedad hipofisaria</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/que-pasa-cuando-suspendes-semaglutida</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Qué pasa cuando suspendes semaglutida? Evidencia STEP-4</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-cronograma-generico-cuando-cada-uno</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Genéricos GLP-1 (2026): cuándo Wegovy, Ozempic, Mounjaro y Zepbound se harán genéricos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/indice-precios-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Índice de precios de GLP-1 compuestos 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-atletas-entrenamiento-resistencia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Pueden los atletas tomar GLP-1? Wegovy, correr y la evidencia honesta</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-tdah-estimulantes-adderall-vyvanse-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Adderall, Vyvanse o Ritalin: la evidencia al combinarlos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-creatina-monohidrato-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Creatina monohidrato con GLP-1: ¿realmente preserva el músculo?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-vs-wegovy-comparacion-directa-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo vs Wegovy: comparación directa de evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-adolescentes-12-17-evidencia-pediatrica</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para adolescentes 12-17: la evidencia pediátrica</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mejores-peptidos-orales-perdida-peso-evidencia-vs-hype</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Mejores péptidos orales para perder peso (2026): evidencia vs hype</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/berberina-vs-glp1-revision-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Berberina vs GLP-1: revisión completa de la evidencia revisada por pares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/tirzepatida-compuesta-vs-semaglutida-compuesta</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatida compuesta vs semaglutida compuesta: diferencias, eficacia y estabilidad</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/tirzepatida-vs-semaglutida-comparacion-directa</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatida vs semaglutida: comparación directa en SURMOUNT y STEP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/metformina-vs-glp1-perdida-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Metformina y antidiabéticos no GLP-1 para pérdida de peso: lo que muestran los ensayos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/select-ensayo-beneficios-cardiovasculares-no-diabeticos</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>SELECT: la semaglutida redujo el riesgo de infarto un 20% en no diabéticos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/suplementos-perdida-peso-glp1-calidad-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Suplementos para perder peso con GLP-1: 16 calificados de A a D vs PubMed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/puedes-tomar-fentermina-con-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Puedes tomar fentermina con un GLP-1? Evidencia de la terapia combinada y preocupaciones</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/diabetes-vs-perdida-peso-glp1-aclaracion-medicamentos</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Medicamento para diabetes y pérdida de peso — Ozempic, Mounjaro, Wegovy, Zepbound (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/naltrexona-contrave-perdida-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Naltrexona para perder peso + cómo actúa Contrave: revisión de evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-pluma-vs-vial-compuesto-diferencias-practicas</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Pluma Wegovy vs vial compuesto: 12 diferencias prácticas antes de cambiar</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/semaglutida-compuesta-mas-barata</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Es real la semaglutida compuesta a $99? Verificamos cada proveedor en el mínimo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-compuesto-movimiento-precio-12-meses</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cómo se movieron los precios del GLP-1 compuesto en los últimos 16 meses</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/bhrt-glp1-perimenopausia-combinacion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>BHRT + GLP-1 en perimenopausia: ¿deberías combinarlos?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-compuesto-reconstitucion-guia-mezcla</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Guía de reconstitución de GLP-1 compuesto: mezclar semaglutida y tirzepatida</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/anthem-glp1-guia-autorizacion-previa</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Anthem y GLP-1: guía de autorización previa para Wegovy, Zepbound y Saxenda</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mejor-supresor-apetito-aprobado-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Mejor supresor del apetito 2026: pastillas, inyecciones y fármacos aprobados por la FDA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/semaglutida-compuesta-bioequivalencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Bioequivalencia de la semaglutida compuesta: qué prueban realmente las farmacias 503A</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/flow-ensayo-semaglutida-enfermedad-renal</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>FLOW: cómo la semaglutida se volvió el primer GLP-1 aprobado para ERC diabética</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/como-tomar-foundayo-orforglipron-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cómo tomar Foundayo (orforglipron): la guía práctica diaria del nuevo GLP-1 oral</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-zepbound-cambio-equivalencia-dosis-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cambio entre Foundayo y Zepbound: equivalencia de dosis según etiqueta FDA (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-efectos-secundarios-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Efectos secundarios de Foundayo (orforglipron): revisión integral de evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-orforglipron-guia-titulacion-semanal</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo (orforglipron) semana a semana 2026: Días 1-90, escala de titulación</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-causa-dano-higado-mash-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Causa daño hepático un GLP-1? Evidencia MASH y MASLD</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-orforglipron-aprobacion-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo (orforglipron) aprobado: la primera píldora GLP-1 oral diaria para perder peso</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-presion-arterial-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Un GLP-1 afecta la presión arterial? Más baja, más alta o ambas — la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cagrisema-redefine-resultados-ensayo</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>CagriSema REDEFINE: lo que mostró realmente la combinación con amilina de Novo Nordisk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/puedes-beber-alcohol-con-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Puedes beber alcohol con un GLP-1? Evidencia de seguridad y antojos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cartas-advertencia-fda-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cartas de advertencia de la FDA a GLP-1 compuesto: investigación en vivo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/antidepresivos-peso-glp1-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Antidepresivos y peso con un GLP-1: ISRS, IRSN, Wellbutrin y la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/bioma-probiotico-perdida-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Funciona el probiótico Bioma para perder peso? Revisión de evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sop-sindrome-ovario-poliquistico-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para SOP (síndrome de ovario poliquístico): evidencia y cobertura 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-psoriasis-eccema-biologico-tnf-inhibidor-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en psoriasis y eccema: evidencia de biológicos e inhibidores de TNF</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-rinitis-alergica-inmunoterapia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y rinitis alérgica: antihistamínicos, SLIT y biológicos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-trastorno-uso-alcohol-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y trastorno por consumo de alcohol: qué muestran los ensayos en 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-higado-graso-mash-guia-paciente-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para hígado graso y MASH: el plan de acción del paciente</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-embarazo-2-meses-lavado-suspension-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y embarazo: la regla de lavado de 2 meses, evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-salud-dental-oral-periodontitis-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y salud dental: periodontitis, boca seca y protocolos de procedimientos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-cancer-tiroides-mtc-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Los GLP-1 causan cáncer? Evidencia sobre MTC, tiroides y páncreas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/por-que-no-pierdo-peso-glp1-meseta</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Por qué no pierdo peso con semaglutida o tirzepatida? Guía de meseta y no respuesta</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-compuesto-vs-marca-guia-decision-paciente-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 compuesto vs de marca: guía de decisión del paciente</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-mas-nuevos-aprobaciones-lanzamientos-recientes</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 más nuevos 2026: aprobaciones y lanzamientos recientes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/piel-flacida-despues-perdida-peso-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Piel flácida tras pérdida rápida de peso con GLP-1: lo que muestra la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cambio-entre-medicamentos-glp1-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cambio Entre Medicamentos GLP-1: La Guía Completa del Protocolo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-no-respondedor-fenotipo-cambio-estrategia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>No respondedores a GLP-1: qué hacer a las 16 semanas con menos de 5%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-creatina-preservacion-masa-magra-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Creatina con GLP-1: preservación de masa magra, hidratación y evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/como-suspender-glp1-seguro-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Cómo suspender semaglutida y tirzepatida de forma segura: guía del protocolo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/ejercicio-glp1-preservacion-masa-magra</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Ejercicio con un GLP-1: pilates, caminar, HIIT y fuerza para preservar masa magra</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-manejo-nausea-guia-practica</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Náusea por GLP-1: guía práctica de manejo (tasas, cronograma y qué ayuda)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-efectos-secundarios-fatiga-caida-cabello-duracion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Duración de efectos secundarios de GLP-1: fatiga, caída del cabello y cuánto duran</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-efectos-secundarios-lo-que-ensayos-mostraron-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Efectos secundarios de GLP-1: lo que los ensayos realmente mostraron</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/que-comer-glp1-dieta-proteina-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Qué Comer con un GLP-1: Guía de Proteína e Hidratación para Semaglutida</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-salud-mental-anhedonia-embotamiento-emocional-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y salud mental (2026): retiro FDA de la advertencia de suicidalidad</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-apnea-sueno-aos-guia-paciente-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound para apnea del sueño (AOS): plan de acción para el paciente</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-caida-cabello-finasterida-minoxidil-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + finasterida o minoxidil para la caída del cabello: la guía</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-dpp4-sitagliptina-januvia-combinacion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Januvia (sitagliptina) más Ozempic: ¿debes combinarlos?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-acne-hormonal-espironolactona-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y acné: resistencia a la insulina, acné hormonal y espironolactona</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-vacunas-gripe-covid-neumococo-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y vacunas: evidencia de respuesta a gripe, COVID y neumococo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/estres-cortisol-glp1-ruido-comida-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Estrés, cortisol y peso con un GLP-1: lo que dice la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-frecuencia-cardiaca-palpitaciones-taquicardia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y Frecuencia Cardíaca: Palpitaciones, Taquicardia y Evidencia de FC en Reposo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-niebla-cerebral-efectos-cognitivos-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Niebla cerebral con GLP-1: qué muestran los estudios cognitivos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-historia-pancreatitis-reto-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 con antecedente de pancreatitis: evidencia de reintroducción</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-covid-prolongado-secuelas-postagudas-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y COVID prolongado: evidencia sobre secuelas postagudas (PASC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-warfarina-eliquis-xarelto-anticoagulantes-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 con warfarina, Eliquis y Xarelto: la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-step-hfpef-tirzepatida-summit-insuficiencia-cardiaca-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para HFpEF: resultados de STEP-HFpEF + SUMMIT con tirzepatida</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-prevencion-perdida-muscular-protocolo-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Prevención de pérdida muscular con GLP-1: protocolo basado en evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-diureticos-furosemida-espironolactona-potasio-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + diuréticos: furosemida, espironolactona y monitoreo del potasio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-quimioterapia-activa-tratamiento-cancer-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 durante quimioterapia activa: qué muestra la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-asma-epoc-funcion-pulmonar-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para asma y EPOC: evidencia de función pulmonar</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-bipolar-litio-estabilizador-animo-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en trastorno bipolar: litio, estabilizadores y evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hpb-tamsulosina-finasterida-urinario-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 e HPB: tamsulosina, finasterida y evidencia urinaria</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sobrevivientes-cancer-mama-tamoxifeno-letrozol-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para sobrevivientes de cáncer de mama con tamoxifeno/letrozol</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-trastorno-atracon-ted-vyvanse-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 para el trastorno por atracón: comparación con Vyvanse y evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-eii-crohn-colitis-ulcerosa-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy con Crohn y Ozempic con colitis ulcerosa: GLP-1 en EII</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-deficiencia-hierro-anemia-ferritina-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y deficiencia de hierro: ferritina, anemia y reposición</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sii-sindrome-intestino-irritable-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 en SII-C y SII-D: Evidencia de Manejo de Síntomas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-erge-ppi-omeprazol-combinacion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Omeprazol o Pantoprazol: Manejo de la ERGE con Ozempic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-estrenimiento-cronico-protocolo-laxantes-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Estreñimiento por GLP-1: el protocolo de laxantes paso a paso que funciona</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-anticonceptivos-seguridad-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Anticonceptivos: advertencia oral de tirzepatida + Wegovy / Ozempic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/amycretin-novo-pipeline-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Amycretin: el dual amilina/GLP-1 de próxima generación de Novo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-metformina-combinacion-perdida-peso-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Combinar GLP-1 y metformina: evidencia de pérdida de peso</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-erc-flow-funcion-renal-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Ensayo FLOW: GLP-1 para ERC estadio 3-4 — la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-cirugia-bariatrica-puente-decision-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 vs Cirugía Bariátrica: Cómo Decidir en 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-fibrilacion-auricular-afib-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 y fibrilación auricular (FA): qué dice la evidencia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mejores-clinicas-trt-testosterona</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Mejores clínicas de TRT 2026: telemedicina de testosterona clasificada</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/trt-glp1-combinacion-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>TRT + GLP-1: La evidencia para combinar testosterona con semaglutida o tirzepatida</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/tirzepatida-compuesta-estado-actual-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>¿Puedes Conseguir Tirzepatida Compuesta en 2026? Estado Actual FDA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-vs-zepbound-cambio-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: evidencia de cambio entre marcas de tirzepatida</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-primeros-30-dias-guia-supervivencia-evidencia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 primeros 30 días: guía de supervivencia de efectos secundarios</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mejores-proveedores-telehealth-disfuncion-erectil</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>Mejores Proveedores Telesalud DE 2026: Reseña Honesta</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hashimotos-thyroiditis-tpo-antibody-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Hashimoto&apos;s: TPO Antibodies, Weight Loss, and Levothyroxine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-chronic-rhinosinusitis-nasal-polyps-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Chronic Rhinosinusitis and Nasal Polyps: Dupixent Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-interstitial-cystitis-bladder-pain-syndrome-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Interstitial Cystitis (IC/BPS): Diet, Elmiron, and Pelvic Floor Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pelvic-floor-dysfunction-prolapse-incontinence-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Pelvic Floor: Stress Incontinence, Prolapse, and PT Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-chronic-urticaria-hives-xolair-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Chronic Urticaria: Xolair, Antihistamines, and Hives Evidence</news:title>
    </news:news>
  </url>
</urlset>